| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $1.06B | +18.6% |
| Cost of Revenue | $180.1M | +6.6% |
| Gross Profit | $878.5M | +21.4% |
| R&D Expense | $285.8M | +3.3% |
| SG&A Expense | $239.5M | -4.2% |
| Operating Income | -$348.3M | +30.5% |
| Pre-tax Income | -$317.6M | +37.8% |
| Income Tax | $10.8M | -26.6% |
| Net Income | -$328.4M |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.40B | -20.7% |
| Short-term Investments | $354.8M | +268.0% |
| Accounts Receivable | $374.2M | +48.5% |
| Current Assets | $2.34B | +2.9% |
| Total Assets | $2.74B | +6.3% |
| Current Liabilities | $626.5M | +18.8% |
| Total Liabilities | $815.0M | +25.3% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.0M | +81.8% |
| Capital Expenditures | $23.8M | +168.2% |
| Investing Cash Flow | -$289.1M | -715.8% |
| Financing Cash Flow | -$60.7M | -104.1% |
| Free Cash Flow | -$33.8M | +47.1% |
| +37.5% |
| EPS (Basic) | -$0.60 | +48.3% |
| EPS (Diluted) | -$0.60 | +48.3% |
| Stockholders' Equity |
| $1.92B |
| -0.1% |